FDA Approved: MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal's generic memantine and donepezil hydrochlorides extended-release combination for the treatment of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine and Donepezil Hydrochlorides Extended-Release (memantine and donepezil hydrochloride extended-release)

Snippet

ORIG AP for MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE (MEMANTINE AND DONEPEZIL)